# Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/adaptive-design-clinical-trials-for-drugs-and-biologics-guidance-for-industry/97c6b6e1-4164-4fbe-8059-b0aa3fd39415

> FDA guidance document: Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry. Issue date: December 02, 2019. Get complete insights and analysis.

---

## Details

- Title: Adaptive Design Clinical Trials for Drugs and Biologics Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2019-12-02
- Last Changed: 2020-04-21
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-3124">FDA-2018-D-3124</a>

## Related Documents

- [Non-Inferiority Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/non-inferiority-clinical-trials/c4be9c7c-051a-4a72-8e2e-d996945a9cd9)
- [Multiple Endpoints in Clinical Trials:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/multiple-endpoints-in-clinical-trials-guidance-for-industry/d08a7428-0534-4dad-83d9-37a60fc5fe62)
- [E17 General Principles for Planning and Design of Multi-Regional Clinical Trials](https://www.globalkeysolutions.net/guidances/guidance-document/e17-general-principles-for-planning-and-design-of-multi-regional-clinical-trials/d2fa5bee-ac83-491d-99ad-7c4d046de439)